CareDx Completes Analytical Validation of AlloSure: A Next-Generation Sequencing Test Measuring Donor-Derived Cell-Free DNA in Transplant Patients
December 23, 2015 08:00 ET
|
CareDx, Inc.
BRISBANE, Calif., Dec. 23, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
CareDx Announces Agreement to Purchase 78 Percent of the Outstanding Shares of Allenex AB and Plans to Launch Tender for Remaining Shares in First Quarter 2016
December 16, 2015 05:02 ET
|
CareDx, Inc.
BRISBANE, Calif., Dec. 16, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
CMS Revises Its Pricing Determination for AlloMap(R)
November 17, 2015 18:35 ET
|
CareDx, Inc.
Reimbursement for Heart Transplant Surveillance Testing to Remain At Previous Level
Decision is Victory for Transplant Community
BRISBANE, Calif., Nov. 17, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc....
CareDx to Participate in Upcoming Investor Conferences
November 17, 2015 16:05 ET
|
CareDx, Inc.
BRISBANE, Calif., Nov. 17, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...
CareDx, Inc. Reports Third Quarter 2015 Financial Results
November 11, 2015 16:05 ET
|
CareDx, Inc.
BRISBANE, Calif., Nov. 11, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...
CareDx Presents Donor-Derived Cell-Free DNA Data at the Association for Molecular Pathology and American Society of Nephrology Annual Meetings
November 09, 2015 16:52 ET
|
CareDx, Inc.
BRISBANE, Calif., Nov. 9, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated,...
CareDx Completes Expansion of CLIA Laboratory With Next-Generation Sequencing Platform Capability
November 02, 2015 17:14 ET
|
CareDx, Inc.
BRISBANE, Calif., Nov. 2, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated,...
CareDx to Release Third Quarter 2015 Financial Results and Host Conference Call on November 11, 2015
October 28, 2015 16:02 ET
|
CareDx, Inc.
BRISBANE, Calif., Oct. 28, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
CareDx CEO to Present at CMS Panel Meeting on Monday, October 19 at 8:45am ET
October 18, 2015 18:00 ET
|
CareDx, Inc.
BRISBANE, Calif., Oct. 18, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
CareDx Announces New Clinical Data on AlloMap Score Variability and Service to Support Assessment of Long-Term Transplant Recipient Risk
October 15, 2015 18:19 ET
|
CareDx, Inc.
BRISBANE, Calif., Oct. 15, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...